Kategorie: Information

Karlsruhe, 23 October 2012. joimax® as the recognized pioneer in endoscopic spine surgery has launched the transforaminal access to the spinal canal under the brand name TESSYS® in 2004. Since then the company has consistently extended its product range and covers the complete array of therapies for spinal disorders with its systems today.

TESSYS® and iLESSYS® are applied especially for the treatment of disc herniations and stenosis utilizing the transforaminal or interlaminar access to the spinal canal, aiming for a long lasting decompression. In the area of pain therapy the company offers the products of the Multiuse series for endoscopic rhizotomy and PeNuts® for percutaneous nucleus therapy. The product range is completed by systems and products in the field of VBA management.

Consequently the next step in the evolution of the joimax® product portfolio is the stabilization and restoration of the spinal column. With the joimax® EndoLIF® programme – the term stands for Endoscopic Lumbar Interbody Fusion – various cage technologies are brought into the intervertebral foramen step by step under endoscopic view. The cage is then being filled with autologous bone or a substitute material under endoscopic control also, the intervertebral disc space and hence the whole spine segment is raised and stabilized. This will be the world’s first interbody fusion device which can be inserted under direct vision.

EndoSphere Spine’s founding members Professors Vijay Goel, PhD and Anand Agarwal, MD at the University of Toledo are among the world leading researchers in the development of biomedical device for the spine. With the assistance of a team at the University of Toledo, they have developed the cage technology, in particular a novel ring cage that is being licensed to joimax® on an exclusive worldwide basis. Prof. Goel is enthusiastic with the idea to position the cage technology using the joimax® minimally invasive access technique: “The combination of our know how with the joimax® expertise leads us to a unique concept that will dramatically push endoscopic spinal surgery forward.” His colleague Prof. Agarwal considers it even a “quantum leap forward”. “In the team at the University of Toledo and the co-founders of EndoSphere Spine, LLC (Profs Goel and Agarwal) we have found a brilliant partner to provide the spine surgeons with state-of-the-art implants for most atraumatic interventions”, adds Wolfgang Ries, CEO and Founder of joimax®.

Both parties share the vision and mission of creating pioneering technologies in order to quickly bring back patients to their usual quality of life in the long run.

About The University of Toledo
Established in 1872, The University of Toledo is home to nearly 22,500 students across 13 colleges and six Ohio campuses. The University offers more than 230 doctoral, professional, graduate and undergraduate programs. UT has earned national and international acclaim for its expertise in medical bioengineering, solar and advanced renewable energy, environmental sciences, astronomical research, translational research and biomarkers.

Right on time with the soon expected registrations of the joimax^® products in Brazil – one of the most emerging BRIC economies – the German-based company showed a very successful presence at the third World Congress of Minimally Invasive Spine Surgery and Techniques (WCMISST) in Salvador de Bahia. The congress was supported by the main International MISS Societies. Almost 2.000 interested participants attended the congress which focused especially on promoting and enhancing the interventional minimally invasive treatment of spine diseases. joimax^® is very proud of being part of this exciting development.

The eight largest emerging and developing economies by either nominal GDP or PPP are the BRIC nations (Brazil, Russia, India and China) as well as Mexico, Turkey, Indonesia, and South Korea. joimax^® is represented in more than 60% of these countries – namely China, Russia, India, South Korea, and Turkey – and observes a fast growing number of registered products in these areas. In Brazil and Mexico submissions with the Health Authorities were started several months ago. The completion is expected in the near future. Then nearly 90% of the growth-leading economies will be covered.

joimax^® provides the complete range of high-quality medical devices for minimally invasive endoscopic spine surgery “Made in Germany”. As a matter of course these devices are CE-marked and FDA-cleared and are sold throughout the European Union and the United States. The specific surgery methods they are used for, were developed by joimax^® together with international experts and opinion leaders for the benefit of the patients:

Less pain, less trauma, less hospitalization, gain back quality of life and be back to work in shorter time!

The advantages are evident. Therefore joimax^® has established a worldwide net of distribution partners allowing that as many patients as possible can get access to these progressive therapy methods.

Other important countries where joimax^® is already present are: South Africa, Israel and Australia. One of the company’s goals within the next few years is to achieve the approval for its devices with the Japanese Ministry of Health.

Emerging and growth-leading economies are the key markets that are expected to lead global growth in the next 10 years. “joimax^® is most pleased with its growing market penetration also in these countries, hence promoting these gentle, patient-friendly and economically beneficial surgery methods for the sake of the patients and of the health insurance systems at the same time”, states Wolfgang Ries, CEO and Founder of joimax®.

Karlsruhe, May 28^th 2012. After the very successful Britspine at the beginning of May in Newcastle in the UK the slogan is now “joimax^® goes oranje“ – up, up and away to the SpineWeek in Amsterdam (May 28^th to June 1^st 2012). This conference is held by the leading international scientific societies in the field of spinal diseases. Up to 3000 participants from all over the world are expected and it is hence the biggest conference of this kind in Europe.

Under the motto “Sharing today’s ideas, shaping tomorrow’s practice” joimax^® invites all its distribution partners to a meeting. Central topic will be joimax^®’s new products and a special focus will be laid on the Deflector Blades for Shrill^® – the Shaver-Drill-System which is indispensible in stenosis treatment. During this meeting Dr. Menno Iprenburg, long standing joimax^® faculty member, will hold a presentation on his own success story. In spring 2010 he had opened his “Ruegkliniek” in Veenhuizen in the Netherlands with an exclusive specialization on endoscopic spine surgery with the joimax^® systems. Right from the start the clinic was very popular. After a consumer program on Dutch TV, where the advantages of the surgery method and very satisfied patients were presented, the staff of Dr. Iprenburg virtually can’t handle the huge demand for appointments for surgery. A really striking success story in medicine!

“joimax^® goes Leipzig” – at the 63^rd annual conference of the DGNC (German Society for Neurosurgery) in Leipzig, Germany (June 13^th to 16^th, 2012), joimax^® will focus on the newest technologies in pain therapy with the Multiuse Set for endoscopic facet joint denervation. Dr. Bernd Illerhaus from Recklinghausen, Germany will talk about his experience with this system during the joimax^® Lunch Symposium on June 14^th, 2012. Assoc. Prof. Dr. Sandro Eustacchio from the University Clinic for Neurosurgery in Graz, Austria will report on the application of TESSYS^® and iLESSYS^® – the transforaminal and interlaminar access systems of joimax^® for the treatment of lumbar herniated discs and spinal canal stenosis.

Of special interest is the fact that the Japanese sister society to the DGNC joins in the meeting this year. Hence, there will be ample opportunity to make important contacts and set further mile stones for the upcoming entry of the Japanese market. In the meantime – thanks to very active partners – business in China and South Korea is steadily increasing – “joimax^® goes Asia”.

Karlsruhe, 20 March 2012. Right on time with the start into a new decade of the joimax^® history, the Karlsruhe-based medical technology company specializing in endoscopic resp. micro-invasive spine surgery will be present at two renowned congresses in March: ISASS from 20 to 23 March 2012 in Barcelona und EndoVienna from 29 March to 1 April 2012 in Vienna.

For the 12th Annual Meeting of ISASS (International Society for the Advancement of Spine Surgery) joimax^® will take part in the exhibition and offer an industry workshop with the motto „Endoscopic Spine Surgery – Following New Paths in Barcelona“. Speakers at this event on 21 March 2012 will be Dr. Choll Kim, San Diego, focussing on the outstanding advantages of endoscopic access techniques especially in the area of the lumbar spine. Followed by Dr. Michael Schubert, Munich, with a presentation of complex cases, extending procedures from the lumbar to the thoracic spine, and varying the access path from the transforaminal to the interlaminar surgery method with the joimax^® instrument systems TESSYS^® und iLESSYS^®.

joimax^® displays the complete product range for endoscopic spinal surgery: Instrument sets for the treatment of disc herniations – with CESSYS^® now being available for the cervical spine –, the novel pain therapy product “Multiuse” for endoscopic facet joint denervation and the iLESSYS^® system for 360° decompression. Further special blades for the Shrill^® shaver-drill resection and ablation system and namely the Shrill^® Deflector Blades for resections „around the corner“, eagerly anticipated by the market, will now be launched.

Preluding the 5th World Congress for Endoscopic Surgery EndoVienna, joimax^® has invited internationally renowned specialists to join a User Meeting with presentations of the joimax^® Faculty members and a workshop to be held at the Institute of Anatomy of the Vienna University. The User Meeting will be dedicated to an intense exchange of knowledge and ideas of the most experienced users of the joimax^® technologies. It will be followed by the keynote lecture of Prof. Dr. G.J. Groen, Utrecht, „High-Resolution Imaging of the Spine: Key to a Better Insight in 3D Relations Within the Spine“, at the opening session of the EndoVienna congress. The program of the „EndoVienna Spine Session“ on 30 March 2012 offers a whole bunch of scientific presentations on the most recent joimax^® products. Members of the international joimax^® faculty team will present their experiences when applying the joimax^® access and resection systems. This session will be chaired by Univ. Doz. Dr. Sandro Eustacchio from the University Hospital Graz.

joimax^® is currently planning its attendance to the upcoming congresses: The 80^th Annual Meeting of the AANS in Miami in April at the first place. The BASS Britspine in early May. End of May Spine Week in Amsterdam. To be followed by SFCR in Strasbourg in June – it is the first time that joimax^® will participate in this congress of the Society of French Spine Surgeons with an exhibition stand and a workshop. Subsequently the company will promote its technologies at the DGNC congress to be held in Leipzig this time. All events focus on industry exhibitions displaying novel product developments and on scientific presence within the conference programs.

San Diego, Oct. 20, 2011 – The Society for Minimally Invasive Spine Surgery (SMISS), San Diego, CA and joimax^®, Karlsruhe, Germany announced today the signing of an agreement to support the SMISS Registry as a founding sponsor for creation and launch of the SMISS Spine Registry for Minimally Invasive Endoscopic Spine Surgery. The SMISS Spine Registry was designed to collect valuable data concerning decreased hospitalization, recovery times, and complication rates of endoscopic spine procedures, as well as increased quality of life measures, subject satisfaction, and cost effectiveness. In today’s rapidly changing healthcare climate, it is imperative to ensure the ongoing availability of this data regarding efficiencies of care and quality of outcomes.

SMISS has assembled an outstanding research team with extensive experience within the spine field. The Principal Investigator for the Registry, Choll Kim, M. D., Ph.D, Executive Director and Board of Directors Member of SMISS states, “We are excited to partner with joimax^® in the launch of the SMISS Registry, a project that will produce the relevant data collection and management necessary for the continued growth of minimally invasive endoscopic spine surgery. The Society will lead the way in the collection of minimally invasive spine surgery outcomes and cost data. SMISS is positioned to become the model for successful spine research.”

“joimax^® and SMISS are ideal partners to begin this important project in spinal endoscopy. The data collected will assist both parties in furthering the development of minimally invasive endoscopic spinal surgery, which is a great benefit to patients around the world,” said Wolfgang Ries, CEO and Founder of joimax. “We are pleased to provide funding for this important project.”

This three year, multi-centered project will commence patient enrollment in late 2011. The Registry is expected to enroll a minimum of 250 patients during the first phase of the project.